Trending...
- Bookmakers Review: Shohei Ohtani Leads 2025 TIME Athlete of the Year Betting Market
- Meet a Scientologist Brings History to Life with Bill and Virginia Watson
- California: Governor Newsom announces appointments 8.12.25
Ivermectin is an antiparasitic medication. Ivermectin has had such a positive impact on global health that in 2015 the Nobel Prize in Physiology or Medicine was awarded to William C. Campbell and Satoshi Ōmura for their discovery of Ivermectin.
SAN LUIS OBISPO, Calif. - Californer -- Ivermectin, a medication recognized with a Nobel Prize for its impact on global health, continues to be a subject of both established medical use and ongoing scientific inquiry. While widely known for its efficacy against parasitic infections, recent scientific interest has also explored its potential in other therapeutic areas, including cancer. Ivermectin is an antiparasitic drug that has been a cornerstone in treating various parasitic diseases in humans for decades. It is FDA-approved for conditions such as intestinal strongyloidiasis and onchocerciasis, playing a critical role in mass drug administration campaigns that have significantly reduced the burden of these debilitating diseases worldwide. Its mechanism of action involves paralyzing and killing parasites. Topical formulations of ivermectin are also approved for conditions like head lice and rosacea. Ivermectin has garnered attention in the scientific community for its potential in other areas, notably in cancer research. Pre-clinical studies (laboratory and animal models) have indicated that ivermectin may exhibit anti-cancer properties by influencing various cellular pathways involved in tumor growth, metastasis, and drug resistance. These early findings suggest potential mechanisms by which ivermectin could inhibit cancer cell proliferation and enhance the effectiveness of conventional cancer therapies. It is crucial to emphasize that while these preliminary findings are a subject of scientific investigation, ivermectin is NOT an FDA-approved treatment for any form of cancer. Research into ivermectin's role in oncology is currently in its early phases, primarily in laboratory settings and limited, early-phase human clinical trials (e.g., Phase I/II studies for specific cancers, often in combination with other immunotherapies). Medical experts strongly caution against the use of ivermectin for cancer treatment outside of controlled clinical trial settings. Self-medication with ivermectin for cancer is not recommended, as its safety and effectiveness for this purpose in humans have not been established. Furthermore, using unapproved medications can lead to serious side effects, drug interactions, and may delay or interfere with proven cancer treatments. Patients with any medical condition, including parasitic infections or cancer, should always consult with qualified healthcare professionals for diagnosis, treatment, and guidance. Relying on unverified information or obtaining medications from unregulated online sources can pose significant health risks. The ongoing research into ivermectin's potential broader applications highlights the continuous quest for new therapeutic strategies. However, until robust, large-scale human clinical trials demonstrate clear safety and efficacy, its use should remain strictly within its approved indications or under the direct supervision of medical professionals.
More on The Californer
Jase Medical: https://jasemedical.com/?rstr=24135
Ivermectin Options: https://jasemedical.com/ivermectin-options?rstr=24135
More on The Californer
- Myth Vs Fact, In Ricardo Salinas False Narrative Of USD $110 Million Loan Drama
- USFITC Completes Export of MS21250 Bolts for International Defense Application
- Long Beach Chooses to Reuse with Bring Your Own Month this October
- Five years since devastating 2020 fire siege: here's how California is better prepared for catastrophic wildfire
- Cheat Codes Grace the Cover of RYM Magazine's Exclusive Double Edition
Jase Medical: https://jasemedical.com/?rstr=24135
Ivermectin Options: https://jasemedical.com/ivermectin-options?rstr=24135
Source: AffiliateMarketingAdvertising.com
Filed Under: Medical
0 Comments
Latest on The Californer
- Dr. Mark Dill Expands Dental Technology Suite in Cleveland, TN with 3D Printing and Panoramic Imaging
- Assent's New EU Deforestation Regulation Solution Helps Manufacturers Ensure Readiness for Urgent Deadline
- Pinnacle Fertility California Expands Elite Physician Team with the Addition of Dr. Kristin Bendikson
- Grayslake Police & Fire Face Off Against "Beat Bob" in Charity Volleyball Showdown – Sept 13th, 2025
- Vintage Toy Marketplace Toyoholic.com Puts Rare Finds at Your Fingertips
- VisualOn & Anyscreen Partner to Offer Turnkey, Efficient Video & Live Streaming with Top Quality
- Best Car Wash in Downey, CA Cheapest Car Wash in Downey
- Voices for Humanity Speaks Out Against Drugs in Fiji with Kalesi Toga Volatabu
- Making Connections Since 1970, Interpreters Unlimited Turns 55
- SANYO DENKI SANMOTION G Servo Systems Certified for Universal Robots MotionPlus
- Glaucoma Research Foundation Appoints Cynthia Steel, PhD, as Chief Scientific Officer
- TOMORROW: Governor Newsom, California leaders to make major announcement in response to Trump's gerrymandering attempts
- Turning Writing from a Hobby into a Thriving Income: The New Era of Author Empowerment
- A New Chapter in Leadership: Announcing Four New Partners at Percy Law Group, PC
- World of Dance Partners with HVY Sleeves to Revolutionize Dance Training
- SatYield Awarded U.S. Patent for Core Yield Estimation Technology
- LawPro.ai Closes Seed Funding Round Amid Strong Product Momentum and Innovation
- ImagineX Named to 2025 Inc. 5000 List of America's Fastest-Growing Private Companies
- OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer
- Alphabet Kids Series Inspires a Global Movement of Imagination and Impact